We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.07B
AUM Growth
-$454M
Cap. Flow
-$243M
Cap. Flow %
-11.76%
Top 10 Hldgs %
86.27%
Holding
32
New
1
Increased
2
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$11.8M
2
OREX
Orexigen Therapeutics, Inc.
OREX
+$4.38M
3
WDAY icon
Workday
WDAY
+$389K

Sector Composition

Rank Sector Weight
1 Healthcare 38.15%
2 Communication Services 33.8%
3 Technology 21.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRPN icon
1
Groupon
GRPN
$1.06B
$640M 30.91%
2,717,579
-3,075
-0.1% -$635K
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$278M 13.45%
9,861,412
CVT
3
DELISTED
CVENT, INC.
CVT
$266M 12.83%
7,299,146
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$137M 6.64%
2,279,781
EPZM
5
DELISTED
Epizyme, Inc
EPZM
$134M 6.48%
6,446,089
+406,500
+7% +$11.8M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.74B
$80.3M 3.88%
10,650,000
ECOM
7
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$69.3M 3.35%
1,661,357
-1,106,340
-40% -$41.1M
FIO
8
DELISTED
FUSION-IO INC COM
FIO
$62.7M 3.03%
7,038,379
MM
9
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$59.8M 2.89%
8,224,752
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$58.3M 2.82%
2,884,221
WIFI
11
DELISTED
Boingo Wireless, Inc.
WIFI
$28.6M 1.38%
4,467,960
-1,000,000
-18% -$6.66M
VIRX
12
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$26.7M 1.29%
26,841
DZSI
13
DELISTED
DZS Inc. Common Stock
DZSI
$25.5M 1.23%
956,258
GLUU
14
DELISTED
Glu Mobile Inc.
GLUU
$23.1M 1.11%
5,943,793
LXRX icon
15
Lexicon Pharmaceuticals
LXRX
$1.03B
$21M 1.02%
1,668,000
NKTR icon
16
Nektar Therapeutics
NKTR
$2.31B
$20.7M 1%
121,707
ITMN
17
DELISTED
INTERMUNE INC
ITMN
$19.8M 0.95%
1,341,000
GYRE icon
18
Gyre Therapeutics
GYRE
$639M
$19M 0.92%
5,799
-8
-0.1% -$31.5K
CADX
19
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$18.7M 0.91%
2,070,286
EXEL icon
20
Exelixis
EXEL
$14.2B
$13.5M 0.65%
2,207,000
FOLD
21
DELISTED
Amicus Therapeutics
FOLD
$13.3M 0.64%
5,653,029
ALIM
22
DELISTED
Alimera Sciences
ALIM
$12.6M 0.61%
178,750
OREX
23
DELISTED
Orexigen Therapeutics, Inc.
OREX
$10.9M 0.53%
193,530
+78,000
+68% +$4.38M
RIGL icon
24
Rigel Pharmaceuticals
RIGL
$715M
$9.24M 0.45%
324,315
SLTM
25
DELISTED
SOLTA MED INC (DE)
SLTM
$8.44M 0.41%
2,859,577

Similar funds

NEA Management Company's Q4 2013 Portfolio in Review

As of Q4 2013, NEA Management Company held 32 positions worth $2.07B, down 18% from $2.52B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

NEA Management Company withdrew a net $243M in Q4 2013, closing 3 positions and reducing 4 holdings. Its most notable exit was XOOM CORP COM, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 40% a quarter earlier, followed by Communication Services and Technology.

Against the trend, NEA Management Company opened a new position in Workday worth $410K.

  • NEA Management Company's largest Q4 2013 buy was Workday: 4,930 shares worth $410K.
  • NEA Management Company added most to Epizyme, Inc in Q4 2013, an estimated $11.8M increase.
  • NEA Management Company's biggest Q4 2013 reduction was CHANNELADVISOR CORPORATION, cutting an estimated $41.1M.
  • NEA Management Company fully exited XOOM CORP COM in Q4 2013, selling an estimated $160M.
  • NEA Management Company's ten largest holdings make up 86% of its $2.07B portfolio in Q4 2013.
  • NEA Management Company opened 1 new position and closed 3 in Q4 2013.
  • NEA Management Company's portfolio value fell 18% quarter-over-quarter to $2.07B.

Based on NEA Management Company's 13F filing for Q4 2013, filed 29 Jan 2014.